Harrow Health Inc
NASDAQ:HROW

Watchlist Manager
Harrow Health Inc Logo
Harrow Health Inc
NASDAQ:HROW
Watchlist
Price: 45.38 USD 5.17% Market Closed
Market Cap: 1.7B USD

Intrinsic Value

The intrinsic value of one HROW stock under the Base Case scenario is 60.52 USD. Compared to the current market price of 45.38 USD, Harrow Health Inc is Undervalued by 25%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

HROW Intrinsic Value
60.52 USD
Undervaluation 25%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Harrow Health Inc

What is Valuation History?
Compare HROW to

Fundamental Analysis

Company Overview
Loading...
Business Segments
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about HROW?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Harrow Health Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Harrow Health Inc

Current Assets 154.9m
Cash & Short-Term Investments 53m
Receivables 79.1m
Other Current Assets 22.9m
Non-Current Assets 190.1m
PP&E 11.7m
Intangibles 178.5m
Efficiency

Free Cash Flow Analysis
Harrow Health Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Harrow Health Inc

Revenue
227.7m USD
Cost of Revenue
-57.9m USD
Gross Profit
169.8m USD
Operating Expenses
-155.4m USD
Operating Income
14.4m USD
Other Expenses
-24.6m USD
Net Income
-10.2m USD
Fundamental Scores

HROW Profitability Score
Profitability Due Diligence

Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

ROE is Increasing
ROIC is Increasing
Exceptional Gross Margin
Strong 3Y Average Gross Margin
42/100
Profitability
Score

Harrow Health Inc's profitability score is 42/100. The higher the profitability score, the more profitable the company is.

HROW Solvency Score
Solvency Due Diligence

Harrow Health Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Negative Net Debt
Low D/E
Long-Term Solvency
Average Altman Z-Score
37/100
Solvency
Score

Harrow Health Inc's solvency score is 37/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

HROW Price Targets Summary
Harrow Health Inc

Wall Street analysts forecast HROW stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for HROW is 61.03 USD with a low forecast of 42.42 USD and a high forecast of 79.8 USD.

Lowest
Price Target
42.42 USD
7% Downside
Average
Price Target
61.03 USD
34% Upside
Highest
Price Target
79.8 USD
76% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Harrow Health Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for HROW is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

HROW Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one HROW stock?

The intrinsic value of one HROW stock under the Base Case scenario is 60.52 USD.

Is HROW stock undervalued or overvalued?

Compared to the current market price of 45.38 USD, Harrow Health Inc is Undervalued by 25%.

Back to Top